Skip to main content
SpringerLink
Log in

Clinical Pharmacokinetics of Probenecid

  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

A review of the clinical applications and of the disposition of probenecid in man, including drug interactions, is presented.

Probenecid is the classical competitive inhibitor of organic acid transport in the kidney and other organs. There are 2 primary clinical uses for probenecid: as a uricosuric agent in the treatment of chronic gout and as an adjunct to enhance blood levels of antibiotics (such as penicillins and Cephalosporins). Adsorption of probenecid is essentially complete following oral administration. The drug is extensively metabolised by glucuronide conjugation and by oxidation of the alkyl side chains; oxidation of the aromatic ring does not occur. The half-life of probenecid in plasma (4 to 12 hours) is dose-dependent. Renal excretion is the major route of elimination of the metabolites; excretion of the parent drug is minimal and is dependent on urinary pH. Probenecid and its oxidised metabolites are extensively bound to plasma proteins, mainly to albumin. Tissue concentrations (based on animal studies) are generally lower than plasma concentrations.

Most of the drug-drug interactions involving probenecid are due to an effect on the kidneyblock of transport of acidic drugs. Similarly probenecid affects the tubular secretion of a number of acidic endogenous substances by the kidney. Probenecid is also involved in the block of transport of acidic metabolites of catecholamines, for example homovanillic and hydroxyindoleacetic acids, in the brain. There are a number of analytical procedures for the assay of probenecid. These are based on spectrophotometry, spectrofluorometry, gas and liquid chromatography and radioimmunoassay.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adams, H., Holmes, K.; Israili, Z. and Dayton, P.: Interaction of probenecid with penicillin G in man. Federation Proceedings 36: 997 (1977).

    Google Scholar 

  • Aherne, G.W.; Marks, V.; Mould, G.P.; Piall, E. and P. White, W.F.: The interaction between methotrexate and probenecid in man. Letter: British Journal of Pharmacology 63: 369P (1978a).

    Google Scholar 

  • Aherne, G.W.; Piall, E.; Marks, V.; Mould, G.P. and White, W.F.: Prolongation and enhancement of serum methotrexate concentrations by probenecid. British Medical Journal 1: 1097–1099 (1978b).

    Article  PubMed  CAS  Google Scholar 

  • Allen, B.W.; Ellard, G.A.; Mitchison, D.A.; Hatfield, A.R.W.; Kenwright, S. and Levi, A.J.: Probenecid and serum rifampicin. Letter: Lancet 2: 1309 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Ashcroft, G.W.; Dow, R.C. and Moir, A.T.B.: The active transport of 5-hydroxyindol-3-ylacetic acid and 3-methoxy-4-hydroxyphenylacetic acid from a recirculatory perfusion system of the cerebral ventricles of the unanaesthetized dog. Journal of Physiology 199: 397–425 (1968).

    PubMed  CAS  Google Scholar 

  • Baber, N.; Halliday, L.; Sibeon, R.; Littler, T. and Orme, M. L’E.: The interaction between indomethacin and probenecid. A clinical and pharmacokinetic study. Clinical Pharmacology and Therapeutics 24: 298–307 (1978).

    PubMed  CAS  Google Scholar 

  • Barac-Nieto, M. and Cohen, J.J.: Nonesterified fatty acid uptake by dog kidney: Effects of probenecid and chlorothiazide. American Journal of Physiology 215: 98–107 (1968).

    PubMed  CAS  Google Scholar 

  • Barza, M.; Brusch, J.; Bergeron, M.G. and Weinstein, L.: Penetration of antibiotics into fibrin loci in vivo. Journal of Infectious Diseases 129: 59–78 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Barza, M. and Weinstein, L.: Some determinants of the distribution of penicillins and Cephalosporins in the body. Practical and theoretical considerations. Annals of the New York Academy of Sciences 235: 613–620 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Bergan, T.; Westlie, L. and Brodwall, E.K.: Influence of probenecid on gentamycin pharmacokinetics. Acta Medica Scandinavica 191: 221–224 (1974).

    Google Scholar 

  • Berndt, W.O.: Probenecid binding by renal cortical slices and homogenates. Proceedings of the Society for Experimental Biology and Medicine 126: 123–126 (1967).

    PubMed  CAS  Google Scholar 

  • Beyer, K.H. Jr; Peters, L.; Woodward, R. and Verwey, W.F.: The enhancement of the physiological economy of penicillin in dogs by the simultaneous administration of para-amino-hippuric acid II. Journal of Pharmacology and Experimental Therapeutics 82: 310–323 (1944).

    CAS  Google Scholar 

  • Beyer, K.H. Jr; Wiebelhaus, V.D.; Tillson, E.K.; Russo, H.F. and Wilhoyte, K.M.: “Benemid”, P-(di-n-propylsulfamyl)-benzoic acid: Inhibition of glycine conjugative reactions. Proceedings of the Society for Experimental Biology and Medicine 74: 772–775 (1950).

    PubMed  CAS  Google Scholar 

  • Beyer, K.H. Jr; Russo, H.F.; Tillson, E.K.; Miller, A.K.; Verwey, W.F. and Gass, S.R.: “Benemid”, p-(di-n-propylsulfamyl)-benzoic acid: its renal affinity and its elimination. American Journal of Physiology 166: 625–640 (1951).

    PubMed  CAS  Google Scholar 

  • Beyer, K.H. Jr: Factors basic to the development of useful inhibitors of renal transport mechanisms. Archives Internationales de Pharmacodynamie et de Therapie 48: 97–117 (1954).

    Google Scholar 

  • Beyer, K.H. Jr: Discovery, Development and Delivery of New Drugs (SP Medical and Scientific Books, division of Spectrum Publications, New York 1979).

    Google Scholar 

  • Bint, A.J.; Reeves, D.S. and Holt, H.A.: Effect of probenecid on serum cefoxitin concentrations. Letter: Journal of Antimicrobial Chemotherapy 3: 627–628 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Bishop, C.; Rand, R. and Talbott, J.H.: The effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on uric acid metabolism in one normal and one gouty subject. Journal of Clinical Investigation 30: 889–895 (1951).

    Article  PubMed  CAS  Google Scholar 

  • Boger, W.P.; Beatty, J.O.; Pitts, F.W. and Flippin, H.F.: The influence of a new benzoic acid derivative on the metabolism of para-aminosalicylic acid (PAS) and penicillin. Annals of Internal Medicine 33: 18–31 (1950a).

    PubMed  CAS  Google Scholar 

  • Boger, W.P.; Forrest, W.P. and Gallagher, M.E.: Benemid and carinamide: Comparison of effect of para-aminosalicylic acid (PAS) plasma concentrations. Journal of Laboratory and Clinical Medicine 36: 276–282 (1950b).

    PubMed  CAS  Google Scholar 

  • Boger, W.P.; Matteucci, W.V. and Beatty, J.O.: “Benemid” p-(din-propylsulfamyl)-benzoic acid: Lack of effect of aureomycin, chloromycetin, streptomycin and terramycin. Proceedings of the Society for Experimental Biology and Medicine 76: 222–225 (1951a).

    PubMed  CAS  Google Scholar 

  • Boger, W.P.; Matteucci, W.V. and Schimmel, N.H.: Renal clearances of penicillin, phenolsulphonphthalein, and para-amminohippurate (PAH) modified by “Benemid”. American Journal of Medicine 11: 517 (1951b).

    Article  Google Scholar 

  • Boger, W.P.; Bayne, G.M.; Gylfe, J. and Wright, L.D.: Renal clearance of pantothenic acid in man: Inhibition by probenecid (“Benemid”). Proceedings of the Society for Experimental Biology and Medicine 82: 604–608 (1953).

    PubMed  CAS  Google Scholar 

  • Bonar, J.A. and Perkins, W.H.: Inhibitors of urinary excretion of iodine131-labeled corticotropin by probenecid. Journal of Clinical Endocrinology 22: 38–42 (1962).

    Article  CAS  Google Scholar 

  • Brater, D.C.: Increase in diuretic effect of chlorothiazide by probenecid. Clinical Pharmacology and Therapeutics 23: 259–265 (1978a).

    PubMed  CAS  Google Scholar 

  • Brater, D.C.: Effects of probenecid and furosemide response. Clinical Pharmacology and Therapeutics 24: 548–554 (1978b).

    PubMed  CAS  Google Scholar 

  • Braun, W. and Schniewind, H.: Die anreicherung von probenecid (35S) in nierenschnitten des meerschweinchens. Naunyn-Schmiedeberg’s Archiv für Experimentelle Pathologie und Pharmakologie 243: 429–438 (1962).

    CAS  Google Scholar 

  • Brook, R.; Schrogie, J.J. and Solomon, H.M.: Failure of probenecid to inhibit the rate of metabolism of tolbutamide in man. Clinical Pharmacology and Therapeutics 9: 314–317 (1968).

    PubMed  CAS  Google Scholar 

  • Burns, J.J.; Cucinell, S.A.; Koster, R. and Conney, A.H.: Application of drug metabolism to drug toxicity studies. Annals of the New York Academy of Sciences 123: 273–286 (1965).

    Article  PubMed  CAS  Google Scholar 

  • Caprio, J.M.; Reynolds, J.; Frank, G.; Carbone, J. and Nishimura, R.: Ampicillin therapy for pharyngeal gonorrhea. Journal of the American Medical Association 239: 1631–1633 (1978).

    Article  PubMed  Google Scholar 

  • Christian, C.L. (Ed.) Nineteenth rheumatism review. Discussion of combined allopurinol and uricosuric therapy. Arthritis and Rheumatism 13: 458–711 (1970).

    Google Scholar 

  • Constant, M.: Distribution of 5,5-dimethyl-2,4-oxazolidinedione in intraocular fluids of rabbits. IV. Distribution of probenecid. Investigative Ophthalmology 6: 492–497 (1967).

    PubMed  CAS  Google Scholar 

  • Conway, W.D. and Melethil, S.: Excretion of probenecid and its metabolites in bile and urine of rats. Journal of Pharmaceutical Sciences 63: 1551–1554 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Conway, W.D. and Melethil, S.: A gas Chromatographic assay for probenecid and its metabolites in biological fluids. Journal of Chromatography 115: 222–227 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Coriell, L.L.; Labra, C.; Saltzman, E. and McNair-Scott, T.F.: An evaluation of benemid p-(di-n-propylsulfamyl)-benzoic acid. Dosage schedule in children. Journal of Pediatrics 42: 292–300 (1953).

    Article  PubMed  CAS  Google Scholar 

  • Cserr, H.F. and Van Dyke, D.H.: 5-Hydroxyindoleacetic acid accumulation by isolated choroid plexus. American Journal of Physiology 220: 718–723 (1971).

    PubMed  CAS  Google Scholar 

  • Cunningham, R.F.; Perel, J.M.; Israili, Z.H. and Dayton, P.G.: Probenecid metabolism in vitro with rat, mouse and human liver preparations. Studies of factors affecting the site of oxidation. Drug Metabolism and Disposition 5: 205–210 (1977).

    PubMed  CAS  Google Scholar 

  • Cunningham, R.F.; Israili, Z.H. and Dayton, P.G.: New spectrophotofluorometric assay for probenecid. Journal of Pharmaceutical Sciences 67: 434–436 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Damm, K.H. and Erttmann, R.: Interaction of probenecid with digitoxin metabolism in rats. Toxicology and Applied Pharmacology 33: 246–257 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Dash, H.R. and Mills, J.: Severe metabolic acidosis associated with nalidixic acid overdose. Letter. Annals of Internal Medicine 84: 570–571 (1976).

    CAS  Google Scholar 

  • Dayton, P.G.; Yü, T.F.; Chen, W.; Berger, L.; West, L.A. and Gutman, A.B.: The physiological disposition of probenecid, including renal clearance, in man, studied by an improved method for its estimation in biological material. Journal of Pharmacology and Experimental Therapeutics 140: 278–286 (1963).

    PubMed  CAS  Google Scholar 

  • Dayton, P.G.; Weiss, M.M. and Perel, J.M.: The effect of probenecid, Phenylbutazone, their analogs on the excretion of L-ascorbic acid in rats. Journal of Medicinal, Chemistry 9: 941–944 (1966).

    Article  CAS  Google Scholar 

  • Dayton, P.G.; Cucinell, S.A.; Weiss, M. and Perel, J.M.: Dose-dependence of drug plasma level decline in dogs. Journal of Pharmacology and Experimental Therapeutics 158: 305–316 (1967).

    PubMed  CAS  Google Scholar 

  • Dayton, P.G. and Perel, J.M.: The metabolism of probenecid in man. Annals of the New York Academy of Sciences 179: 399–402 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Dayiuu, F.G.; Israili, Z.H. and Perel, J.M. Influence of binding on drug metabolism and distribution. Annals of the New York Academy of Sciences 226: 172–194 (1973a).

    Article  Google Scholar 

  • Dayton, P.G.; Perel, J.M.; Cunningham, R.F.; Israili, Z.H. and Weiner, I.M.: Studies of the fate of metabolites and analogs of probenecid. The significance of metabolic sites, especially lack of ring hydroxylation. Drug Metabolism and Disposition 1: 742–751 (1973b).

    PubMed  CAS  Google Scholar 

  • Despopoulos, A. and Weissbach, H.: Renal metabolism of 5-hydroxyindolacetic acid. American Journal of Physiology 189: 548–550 (1957).

    PubMed  CAS  Google Scholar 

  • Diamond, H.S. and Meisel, A.D.: Effect of pharmacological inhibitors on urate transport during induced uricosuria. Clinical Science and Molecular Medicine 53: 133–140 (1977).

    PubMed  CAS  Google Scholar 

  • Dubin, A.; Kushner, D.S.; Bronsky, D. and Pascale, L.R.: Hyperuricemia in hypoparathyroidism. Metabolism 5: 703–709 (1956).

    PubMed  CAS  Google Scholar 

  • Dunner, D.L.; Heiber, S. and Perel, J.M.: The effect of L-tryptophan administration on the concentration of probenecid in plasma and cerebrospinal fluid in patients. Psychopharmacology 53: 305–308 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Eickhoff, T.C.; Kislak, J.W. and Finland, M.: Sodium ampicillin: Absorption and excretion of intramuscular and intravenous doses in normal young men. American Journal of Medical Sciences 249: 163–171 (1965).

    Article  CAS  Google Scholar 

  • Elion, G.B.; Kovensky, A. and Hitchings, G.H.: Metabolic studies of allopurinol, an inhibitor of xanthine oxidase. Biochemical Pharmacology 15: 863–880 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Elion, G.B.; Yü, T.F.; Gutman, A.B. and Hitchings, G.H.: Renal clearance of oxipurinol, the chief metabolite of allopurinol. American Journal of Medicine 45: 69–77 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Erttmann, R. and Damm, K.H.: Probenecid and hepatic transport of JH-ouabain in rats. Archives Internationales de Pharmacodynamie et de Therapie 211: 197–210 (1974).

    PubMed  CAS  Google Scholar 

  • Fallon, R.J.; Lees, A.W.; Allan, G.W.; Smith, J. and Tyrell, W.F.: Probenecid and rifampicin serum levels. Lancet 2: 792–794 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Fanelli, G.M. Jr. and Weiner, I.M.: Urate Excretion: Drug Interactions. Journal of Pharmacology and Experimental Therapeutics 210: 186–195 (1979).

    PubMed  CAS  Google Scholar 

  • Faull, K.F.; Do-Amaral, J.R. and Barchas, J.D.: Selective ion monitoring assay for probenecid. Biomedical Mass Spectrometry 5: 317–320 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Forbes, M. and Becker, B.: The transport of organic anions by the rabbit eye. II. In vivo transport of iodopyracet (Diodrast). American Journal of Ophthalmology 50: 867–875 (1960).

    PubMed  CAS  Google Scholar 

  • Frey, H.H. and Loscher, W.: Distribution of Valproate across the interface between blood and cerebrospinal fluid. Neuropharmacology 17: 637–642 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Gardner, L.I.; Crigler, J.R. Jr and Migeon, C.J.: Inhibition of urinary 17-ketosteroid excretion produced by “Benemid”. Proceedings of the Society for Experimental Biology and Medicine 78: 460–463 (1951).

    PubMed  CAS  Google Scholar 

  • Glbaldi, M. and Schwartz, M.A.: Apparent effect of probenecid on the distribution of penicillins in man. Clinical Pharmacology and Therapeutics 9: 345–349 (1968).

    Google Scholar 

  • Gibaldi, M.; Davidson, D; Plaut, M.E. and Schwartz, M.A.: Modification of penicillin distribution and elimination by probenecid. International Zeitschrift für Klinische Pharmakologie und Therapie Toxikologie 3: 182–189 (1970)

    CAS  Google Scholar 

  • Goodwin, C.S. and Sparell, G.: Inhibition of dapsone excretion by probenecid. Lancet 2: 884–885 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Goodwin, C.S.; Raftery, E.B.; Goldberg, A.D.; Skeggs, H.; Till, A.E. and Martin, C.M.: Effects of rate of infusion of probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: Comparison with cepholothin. Antimicrobial Agents and Chemotherapy 6: 338–346 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Griffith, R.S.; Black, H.R.; Brier, G.L. and Wolny, J.D.: Effect of probenecid on the blood levels and urinary excretion of cefamandole. Antimicrobial Agents and Chemotherapy 11: 809–812 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Guarino, A.M. and Schanker, L.S.: Biliary excretion of probenecid and its glucuronide. Journal of Pharmacology and Experimental Therapeutics 164: 387–395 (1968).

    PubMed  CAS  Google Scholar 

  • Guarino, A.M.; Conway, W.D. and Fales, H.M.: Mass spectral identification of probenecid metabolites in rat bile. European Journal of Pharmacology 8: 244–252 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Gutman, A.B.: Uric acid metabolism and gout. American Journal of Medicine 9: 799–817 (1950).

    Article  Google Scholar 

  • Gutman, A.B.: Some recent advances in the study of uric acid metabolism and gout. Bulletin of the New York Academy of Medicine 27: 144–164 (1951a).

    PubMed  CAS  Google Scholar 

  • Gutman, A.B.: Management of gouty arthritis. Bulletin on Rheumatic Diseases 1: 11–12 (1951b).

    PubMed  CAS  Google Scholar 

  • Gutman, A.B. and Yü, T.F.: Benemid (p-[di-n-propylsulfamyl]-benzoic acid) as uricosuric agent in chronic gouty arthritis. Transactions of the association of American Physicians 64: 279–288 (1951).

    PubMed  CAS  Google Scholar 

  • Gutman, A.B.; Yü, T.F. and Sirota, J.H.: A study, by simultaneous clearance techniques, of salicylate excretion in man. Effect of alkalinization of the urine by bicarbonate administration; effect of probenecid. Journal of Clinical Investigation 34: 711–721 (1955).

    Article  PubMed  CAS  Google Scholar 

  • Gutman, A.B.: Uricosuric drugs, with special reference to probenecid and sulfinpyrazone. Advances in Pharmacology 4: 91–142 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Hansen, J.M. and Christensen, L.K.: Drug interactions with oral sulphonylurea hypoglycaemic drugs. Drugs 13: 24–34 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Harle, R.K. and Cowen, T.: Determination of probenecid in serum by high performance liquid chromatography. The Analyst 103: 492–496 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Hodgin, V.G. Jr: Antibiotics in the treatment of chronic staphylococcal osteomyelitis. Southern Medical Journal 68: 817–823 (1975).

    Article  PubMed  Google Scholar 

  • Homeida, M; Roberts, C. and Branch, R.A.: Influence of probenecid and Spironolactone on furosemide kinetics and dynamics in man. Clinical Pharmacology and Therapeutics 22: 402–409 (1977).

    PubMed  CAS  Google Scholar 

  • Honari, J.; Blair, A.D. and Cutler, R.E.: Effects of probenecid on furosemide kinetics and natriutresis in man. Clinical Pharmacology and Therapeutics 22: 395–401 (1977).

    PubMed  CAS  Google Scholar 

  • Horwitz, D.; Thorgeirsson, S.S. and Mitchell, J.R.: The influence of allopurinol and size of dose on the metabolism of Phenylbutazone in patients with gout. European Journal of Clinical Pharmacology 12: 133–136 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Howell, S.B.; Olshen, R.A. and Rice, J.A.: Effect of probenecid on cerebrospinal fluid methotrexate kinetics. Clinical Pharmacology and Therapeutics 26: 641–646 (1979).

    PubMed  CAS  Google Scholar 

  • Huang, K.C.: Renal excretion of L-tyrosine and its derivatives. Journal of Pharmacology and Experimental Therapeutics 134: 257–265 (1961).

    PubMed  CAS  Google Scholar 

  • Hutchison, J.C.; Wilkinson, W.H. and McMahon, F.G.: Drug-induced hyperuricemia prevented by probenecid. Journal of Medicine 2: 45–59 (1971).

    PubMed  CAS  Google Scholar 

  • Israel, K.S.; Black, H.R.; Nelson, R.L.; Brunson, M.K.; Nash, J.F.; Brier, G.L. and Wolney, J.D.: Cinoxacin: Pharmacokinetics and the effect of probenecid. Journal of Clinical Pharmacology 18: 491–499 (1978).

    PubMed  CAS  Google Scholar 

  • Israili, Z.H.; Perel, J.M.; Cunningham, R.F.; Dayton, P.G.; Yü, T.F.; Gutman, A.B.; Long, K.R.; Long, R.C. Jr and Golstein, JH.: Metabolites of probenecid. Chemical, physical, and pharmacological studies. Journal of Medicinal Chemistry 15: 709–713 (1972).

    Article  CAS  Google Scholar 

  • Israili, Z.H.; Soliman, A.M.; Cunningham, R.F.; Plowden, J.F. and Keller, J.W.: The interaction of methotrexate and probenecid in man and dog. Proceedings of the American Association for Cancer Research 19: 194 (1978).

    Google Scholar 

  • Jusko, W.J. and Levy, G.: Effect of probenecid on riboflavin absorption and excretion in man. Journal of Pharmaceutical Sciences 56: 1145–1149 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Karney, W.W.; Turck, M. and Holmes, K.K.: Comparative therapeutic and pharmacological evaluation of amoxicillin and ampicillin plus probenecid for the treatment of gonorrhea. Antimicrobial Agents and Chemotherapy 5: 114–118 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Kaplan, K.; Reisberg, B.E. and Weinstein, L.: Cephaloridine: antimicrobial activity and pharmacologic behavior. American Journal of Medical Sciences 253: 667–674 (1967).

    Article  CAS  Google Scholar 

  • Kenwright, S. and Levi, A.J.: Impairment of hepatic uptake of rifamycin antibiotics by probenecid, and its therapeutic implications. Lancet 2: 1401–1405 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Kinsella, J.L.; Holohan, P.D.; Pessah, N.I. and Ross, C.R.: Transport of organic ions in renal cortical luminal and antiluminal membrane vesicles. Journal of Pharmacology and Experimental Therapeutics 209: 443–450 (1979).

    PubMed  CAS  Google Scholar 

  • Klein, J.O. and Finland, M.: Nafcillin, antibacterial action in vitro and absorption and excretion in normal young men. American Journal of Medical Sciences 246: 10–26 (1963).

    Article  CAS  Google Scholar 

  • Korf, J. and Van Praag, H.M.: The intravenous probenecid test A possible aid in evaluation of the serotonin hypothesis on the pathogenesis of depressions. Psychopharmacologia 18: 129–132 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Korf, J. and Van Praag, H.M.: Amine metabolism in the human brain: Further evaluation of the probenecid test. Brain Research 35: 221–230 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Lant, A.F.: Effects of bumetanide on cation and anion transport. Postgraduate Medical Journal 51(Suppl. 6): 35–42 (1975).

    PubMed  CAS  Google Scholar 

  • Levi, A.J.; Gatmaitan, Z. and Arias, I.M.: Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anions. Journal of Clinical Investigation 48: 2156–2167 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Lyness, W.H. and Mycek, M.J.: Clearance of centrally administered phenobarbital in tolerant and nontolerant rats. Federation Proceedings 36: 1040 (1977).

    Google Scholar 

  • Markkanen, T.; Toivanen, P.; Toivanen, A. and Sotaniemi, E.: The effect of probenecid (p-di-n-propyl-sulfamylbenzoic acid) on the spontaneous renal excretion of biologically active metabolites of thiamine, riboflavin and pantothenic acid. Scandinavian Journal of Clinical Laboratory Investigations 15: 511–516 (1963).

    Article  CAS  Google Scholar 

  • Melethil, S. and Conway, W.D.: Urinary excretion of probenecid and its metabolites in humans as a function of dose. Journal of Pharmaceutical Sciences 65: 861–865 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Mu, J.Y.; Faraj, B.A.; Israili, Z.H. and Dayton, P.G.: Studies of the specificity of an antibody directed against probenecid. Investigations with probenecid analogs. Life Sciences 14: 837–852 (1974).

    CAS  Google Scholar 

  • Neff, N.H.; Tozer, T.N. and Brodie, B.B.: Application of steadystate kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma. Journal of Pharmacology and Experimental Therapeutics 158: 214–218 (1967).

    CAS  Google Scholar 

  • Perel, J.M.; Dayton, P.G.; Snell, M.M.; Yü, T.F. and Gutman, A.B.: Studies of interactions among drugs in man at the renal level: probenecid and sulfinpyrazone. Clinical Pharmacology, and Therapeutics 10: 834–840 (1969).

    CAS  Google Scholar 

  • Perel, J.M.; Cunningham, R.F.; Fales, H.M. and Dayton, P.G.: Identification and renal excretion of probenecid metabolites in man. Life Sciences 9: 1337–1343 (1970).

    Article  CAS  Google Scholar 

  • Perel, J.M.; Dayton, P.G.; Yü, T.F. and Gutman, A.B.: Studies of the renal excretion of probenecid acylglucuronide in man. European Journal of Clinical Pharmacology 3: 106–112 (1971).

    Article  CAS  Google Scholar 

  • Perel, J.M.; Levitt, M. and Dunner, D.L.: Plasma and cerebrospinal fluid probenecid concentrations as related to accumulation of acidic biogenic amine metabolites in man. Psychopharmacologia 35: 83–90 (1974).

    Article  CAS  Google Scholar 

  • Poulsen, H.: Inhibition of uric acid excretion in rabbits given probenecid or salicylic acid. Acta Pharmacologica Toxicologia 11: 277–286 (1955).

    Article  CAS  Google Scholar 

  • Rammelkamp, C.H. and Bradley, S.E.: Excretion of probenecid in man Proceedings of the Society for Experimental Biology and Medicine 53: 30–32 (1943).

    CAS  Google Scholar 

  • Recker, R.R.: Effect of hydrochlorothiazide on phosphorus during treatment with diphosphonate. Clinical Pharmacology and Therapeutics 18: 345–349 (1975).

    PubMed  CAS  Google Scholar 

  • Reeves, D.S.; Bint, A.J.; Holt, H.A. and Stocks, P.J.: Cefoxitin sodium: A clinical and pharmacological study. Journal of Antimicrobial Chemotherapy 4B(Suppl.): 155–160 (1978).

    Article  Google Scholar 

  • Rein, M.F.; Westervelt, F.B. and Sande, M.A.: Pharmacodynamics of cefazolin in the presence of normal and impaired renal function. Antimicrobial Agents and Chemotherapy 4: 366–371 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Rennick, B. and Quebbemann, A.J.: Renal tubular excretion of drugs: Proximal tubule secretion and metabolism; in Fisher (Ed) Renal Pharmacology, pp.67–84 (Appleton-Century Crofts, New York 1971).

    Google Scholar 

  • Roche-Ramel, F. and Peters, G.: Urinary excretion of uric acid in nonhuman mammalian species; in Kelley and Weiner (Eds) Handbook of Experimental Pharmacology. Uric Acid, vol. 51, pp.211–255 (Springer-Verlag, Berlin 1978).

    Chapter  Google Scholar 

  • Roos, B.E.; Anden, N.E. and Werdinius, B.: Effect of drugs on the levels of indole and phenolic acids in the central nervous system. International Journal of Neuro-Pharmacology 3: 117–122 (1964).

    CAS  Google Scholar 

  • Runkel, R.; Mroszczak, E.; Chaplin, M.; Sevelius, H. and Segre, E.: Naproxen-probenecid interaction. Clinical Pharmacology and Therapeutics 24: 706–713 (1978).

    PubMed  CAS  Google Scholar 

  • Sabath, L.D.; Klein, J.O. and Finland, M.: Ancillin (2-biphenylpenicillin), antimicrobial activity and clinical pharmacology. American Journal of Medical Sciences 246: 129–146 (1963).

    Article  CAS  Google Scholar 

  • Sabih, K.; Klassen, C.D. and Sabih, K.: Combined G.C. and high resolution mass spectrometric determination with probenecid. Journal of Pharmaceutical Sciences 60: 745–748 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Sanchez, G.: Letter: Enhancement of heparin effect by probenecid. New England Journal of Medicine 292: 48 (1975).

    PubMed  CAS  Google Scholar 

  • Schachter, D. and Taggart, J.V.: Benzoyl coenzyme A and hippurate synthesis. Journal of Biological Chemistry 203: 925–933 (1953).

    PubMed  CAS  Google Scholar 

  • Schachter, D.: The chemical estimation of acyl glucuronides and its application to studies on the metabolism of benzoate and salicylate in man. Journal of Clinical Investigation 36: 297–302 (1957).

    Article  PubMed  CAS  Google Scholar 

  • Schrogie, J.J.; Davies, R.O.; Yeh, K.C.; Rogers, D.; Holmes, G.I.; Skeggs, H. and Martin, C.M.: Bioavailability and pharmacokinetics of cefoxitin sodium. Journal of Antimicrobial Chemotherapy 4B(Suppl.): 69–78 (1978).

    Article  Google Scholar 

  • Shei, W.L.; Mu, J.Y.; Cunningham, R.F.; Israili, Z.H. and Dayton, P.G.: Probenecid in CSF and plasma of rabbits and dogs measured by radioimmunoassay. Psychopharmacology 53: 315–318 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Shore, P.A.; Brodie, B.B. and Hogben, C.A.M.: The gastric secretion of drugs: a pH partition hypothesis. Journal of Pharmacology and Experimental Therapeutics 119: 361–369 (1957).

    PubMed  CAS  Google Scholar 

  • Sirota, J.H.; Yü, T.F. and Gutman, A.B.: Effect of benemid (p-[d1-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects. Journal of Clinical Investigation 31: 692–701 (1952).

    Article  PubMed  CAS  Google Scholar 

  • Sjöström, R.: Steady-state levels of probenecid and their relation to acid monoamine metabolites in human cerebrospinal fluid. Psychopharmacologia 25: 96–100 (1972).

    Article  PubMed  Google Scholar 

  • Skeith, M.D.; Simkin, P.A. and Healey, L.A.: The renal excretion of indomethacin and its inhibition by probenecid. Clinical Pharmacology and Therapeutics 9: 89–93 (1968).

    PubMed  CAS  Google Scholar 

  • Smith, H.W.; Goldring, W. and Chassis, H.: The measurement of the tubular excretory mass, effective blood flow, and filtration rate in the normal human kidney. Journal of Clinical Investigation 17: 263–278 (1938).

    Article  PubMed  CAS  Google Scholar 

  • Talbott, J.H.; Bishop, C.; Norcross, B.M. and Lockie, L.M.: The clinical and metabolic effects of benemid in patients with gout. Transactions of the Association of American Physicians 64: 372–377 (1951).

    PubMed  CAS  Google Scholar 

  • Talbott, J.H. and Yü, T.F.: Gout and Uric Acid Metabolism, pp.225–230 (Stratton Intercontinental Medical Book Corporation, New York 1976).

    Google Scholar 

  • Talseth, T.; Haegele, K.D.; McNay, J.L.; Skrdlant, H.B.; Clement, W.A. and Shepherd, A.M.M.: Pharmacokinetics and cardiovascular effects in rabbits of a major hydralazine metabolite, the hydralazine pyruvic-acid hydrazone. Journal of Pharmacology and Experimental Therapeutics 211: 509 (1979).

    PubMed  CAS  Google Scholar 

  • Tamarkin, N.R.; Goodwin, F.K. and Axelrod, J.: Rapid elevation of biogenic amine metabolites in human CSF following probenecid. Life Sciences 9: 1397–1408 (1970).

    Article  CAS  Google Scholar 

  • Thompson, J.H.: Influence of drugs on laboratory tests; in Bevan (Ed) Essentials of Pharmacology, pp.579–602 (Harper and Row, New York, 1976).

    Google Scholar 

  • Tillson, E.K.; Schuchardt, C.S.; Pitt, A.A.; Gass, R.W. and Beyer, K.H. Jr: “Benemid” (p-[di-n-propylsulfamyl]-benzoic acid): an anticatabolite: its estimation in body fluids. Federation Proceedings 9: 320 (1950).

    Google Scholar 

  • Tillson, E.K.; Schuchardt, C.S.; Fishman, J.H. and Beyer, K.H. Jr: The determination of probenecid (Benemid) in body fluids. Journal of Pharmacology and Experimental Therapeutics 111: 385–394 (1954a).

    PubMed  CAS  Google Scholar 

  • Tillson, E.K.; Pusey, N.W. and Beyer, K.H. Jr: N-alkylsulfamylbenzoic acids: spectrophotometric determination of a series from p-sulfamylbenzoic acid through N-(di-n-propylsulfamyl)-benzoic acid, benemid, in plasma and urine. Journal of Pharmacology and Experimental Therapeutics 112: 252–256 (1954b).

    PubMed  CAS  Google Scholar 

  • Tjandramaga, T.B.; Cucinell, S.A.; Israili, Z.H.; Perel, J.M.; Dayton, P.G.; Yü, T.F. and Gutman, A.B.: Observations on the disposition of probenecid in patients receiving allopurinol. Pharmacology 8: 259–272 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Van Praag, H.M. and Korf, J.: A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients. Biological Psychiatry 3: 105–112 (1971).

    PubMed  Google Scholar 

  • Van Praag, H.M.; Korf, J.; Dols, L.C.W, and Schut, T.: A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant. Psychopharmacologia 25: 14–21 (1972).

    Article  PubMed  Google Scholar 

  • Watson, E. and Wilk, S.: Determination of probenecid in small volumes of cerebrospinal fluid. Journal of Neurochemistry 21: 1569–1571 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Weiner, I.M.; Washington, J.A. II, and Mudge, G.H.: On the mechanism of action of probenecid on renal tubular secretion. Bulletin of the Johns Hopkins Hospital 106: 333–340 (1960).

    PubMed  CAS  Google Scholar 

  • Weiner, I.M. and Mudge, G.H.: Renal tubular mechanisms for excretion of organic acids and bases. American Journal of Medicine 36: 743–762 (1964).

    Article  PubMed  CAS  Google Scholar 

  • Weiner, I.M.: Urate transport in the nephron. American Journal of Physiology 237: F85–F92 (1979).

    PubMed  CAS  Google Scholar 

  • Welling, P.G.; Dean, S.; Selen, A.; Kendall, M.J. and Wise, R.: Probenecid: An unexplained effect on Cephalosporin pharmacology. British Journal of Clinical Pharmacology 8: 491–495 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Werdinius, B.: Effect of probenecid on the levels of monamine metabolites in the rat brain. Acta Pharmacologica Toxicologia 25: 18–23 (1967).

    Article  CAS  Google Scholar 

  • Williams, W.M. and Huang, K.C.: In vitro and in vivo renal tubular transport of tryptophan derivatives. American Journal of Physiology 219: 1468–1474 (1970).

    PubMed  CAS  Google Scholar 

  • Wolfson, W.Q.; Conn, C.; Levine, R. and Huddlestun, B.: Transport and excretion of uric acid in man. III. Physiological significance of the uricosuric effect of carinamide. American Journal of Medicine 4: 774 (1948).

    Article  Google Scholar 

  • Yii, T.F. and Perel, J.: Pharmacokinetic and clinical studies of carprofen in gout. Journal of Clinical Pharmacology 20: 347–351 (1980).

    Article  Google Scholar 

  • Yü, T.F.; Perel, J.M.; Berger, L.; Roboz, J.; Israili, Z.H. and Dayton, P.G.: The effect of the interaction of pyrazinamide and probenecid on urinary uric acid excretion in man. American Journal of Medicine 63: 723–728 (1977).

    Article  PubMed  Google Scholar 

  • Zacchei, A.G. and Weidner, L.: GLC determination of probenecid in biological fluids. Journal of Pharmaceutical Sciences 62: 1972–1975 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Zarro, V.J.: Pharmacology of gout; in Lowenthal and Major (Eds) Clinical Therapeutics, pp.343–346 (Grune and Stratton, New York 1978).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Emory University, Atlanta, Georgia, USA

    R. F. Cunningham, Z. H. Israili & P. G. Dayton

  2. Atlanta VA Medical Center, Decatur, Georgia, USA

    R. F. Cunningham, Z. H. Israili & P. G. Dayton

  3. Highland Drive VA Medical Center, Pittsburgh, Pennsylvania, USA

    R. F. Cunningham, Z. H. Israili & P. G. Dayton

  4. Department of Psychiatry, University of Pittsburgh, Pennsylvania, USA

    R. F. Cunningham, Z. H. Israili & P. G. Dayton

Authors
  1. R. F. Cunningham
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Z. H. Israili
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. G. Dayton
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cunningham, R.F., Israili, Z.H. & Dayton, P.G. Clinical Pharmacokinetics of Probenecid. Clin Pharmacokinet 6, 135–151 (1981). https://doi.org/10.2165/00003088-198106020-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198106020-00004

Keywords

Search

Navigation